pharma · Scabies · Bioequivalence trial in healthy volunteers
Alphapharm
Alphapharm Pty Ltd
Alphapharm Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Scabies, Bioequivalence trial in healthy volunteers, moderate to severely inflamed candidiasis of the skin, Mild to mod
Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU HQ
1982 Founded
187 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
- Founded
- 1982
- Employees
- 187
- Programs
- 30
- Drugs
- 235
- Patents
- 12
PTT101
Phase 2 · small molecule · Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary
PTT101 for Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary is a Phase 2 program (small_molecule) at Alphapharm Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code PTT101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alphapharm Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary
- Status
- active
- Trials
- 1